Janus Henderson Group PLC Charles River Laboratories International, Inc. Transaction History

Janus Henderson Group PLC

$207 Billion
Q3 2025

A detailed history of Janus Henderson Group PLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 23,655 shares of CRL stock, worth $3.97 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

23,655

Previous 23,655 -0.0%

Holding current value

$3.97 Million

Previous $3.59 Million 3.12%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$99.75 - $151.89 $54,663 - $83,235	-548 Reduced 2.26%	23,655 $3.59 Million
Q1 2025 May 15, 2025	SELL	$150.52 - $190.14 $4.83 Million - $6.1 Million	-32,085 Reduced 57.0%	24,203 $3.64 Million
Q4 2024 Feb 14, 2025	BUY	$178.58 - $220.69 $1.83 Million - $2.27 Million	10,270 Added 22.32%	56,288 $10.4 Million
Q3 2024 Nov 14, 2024	BUY	$187.96 - $245.29 $614,253 - $801,607	3,268 Added 7.64%	46,018 $9.07 Million
Q2 2024 Aug 14, 2024	SELL	$206.39 - $268.73 $788,616 - $1.03 Million	-3,821 Reduced 8.2%	42,750 $8.83 Million

Q1 2024 May 15, 2024	SELL	$203.52 - $273.43 $6.71 Million - $9.01 Million	-32,964 Reduced 41.45%	46,571 $12.6 Million
Q4 2023 Feb 14, 2024	BUY	$164.52 - $238.84 $1.41 Million - $2.04 Million	8,555 Added 12.05%	79,535 $18.8 Million
Q3 2023 Nov 14, 2023	SELL	$194.44 - $217.61 $3.38 Million - $3.78 Million	-17,369 Reduced 19.66%	70,980 $13.9 Million
Q2 2023 Aug 14, 2023	SELL	$183.71 - $210.25 $4.72 Million - $5.41 Million	-25,713 Reduced 22.54%	88,349 $18.6 Million
Q1 2023 May 15, 2023	BUY	$191.89 - $259.92 $8.71 Million - $11.8 Million	45,383 Added 66.08%	114,062 $23 Million
Q4 2022 Feb 14, 2023	BUY	$197.11 - $250.07 $13.5 Million - $17.2 Million	68,679 New	68,679 $15 Million
Q3 2022 Nov 14, 2022	SELL	$182.44 - $250.54 $124,059 - $170,367	-680 Reduced 14.02%	4,171 $822,000
Q2 2022 Aug 15, 2022	SELL	$204.13 - $302.4 $2 Million - $2.97 Million	-9,822 Reduced 66.94%	4,851 $1.04 Million
Q1 2022 May 16, 2022	BUY	$255.51 - $362.11 $2.15 Million - $3.05 Million	8,421 Added 134.69%	14,673 $4.17 Million
Q4 2021 Feb 14, 2022	BUY	$351.38 - $448.68 $44,625 - $56,982	127 Added 2.07%	6,252 $2.36 Million
Q3 2021 Nov 16, 2021	SELL	$372.64 - $458.3 $4.28 Million - $5.27 Million	-11,489 Reduced 65.23%	6,125 $2.53 Million
Q2 2021 Aug 16, 2021	BUY	$294.17 - $371.65 $5.18 Million - $6.55 Million	17,614 New	17,614 $6.52 Million
Q1 2020 May 14, 2020	SELL	$98.9 - $178.34 $1.23 Million - $2.21 Million	-12,399 Closed	0 $0
Q4 2019 Feb 18, 2020	SELL	$126.05 - $152.76 $2.64 Million - $3.2 Million	-20,968 Reduced 62.84%	12,399 $1.89 Million
Q3 2019 Nov 14, 2019	SELL	$125.07 - $143.67 $4.67 Million - $5.36 Million	-37,309 Reduced 52.79%	33,367 $4.42 Million
Q2 2019 Jul 31, 2019	BUY	$123.4 - $148.55 $2.5 Million - $3.01 Million	20,293 Added 40.28%	70,676 $10 Million
Q1 2019 Apr 30, 2019	SELL	$104.82 - $146.73 $3.22 Million - $4.5 Million	-30,682 Reduced 37.85%	50,383 $7.32 Million
Q4 2018 Feb 06, 2019	BUY	$105.09 - $137.23 $3.21 Million - $4.19 Million	30,565 Added 60.52%	81,065 $9.18 Million
Q3 2018 Nov 09, 2018	BUY	$112.11 - $134.54 $571,761 - $686,154	5,100 Added 11.23%	50,500 $6.79 Million
Q2 2018 Aug 10, 2018	SELL	$102.37 - $117.25 $1.1 Million - $1.25 Million	-10,700 Reduced 19.07%	45,400 $5.1 Million
Q1 2018 May 14, 2018	BUY	$98.19 - $115.2 $490,950 - $576,000	5,000 Added 9.78%	56,100 $5.99 Million
Q4 2017 Feb 09, 2018	BUY	$100.43 - $118.09 $4.71 Million - $5.54 Million	46,900 Added 1116.67%	51,100 $5.59 Million
Q3 2017 Nov 14, 2017	BUY	$96.72 - $109.26 $406,224 - $458,892	4,200	4,200 $0

Others Institutions Holding CRL

# of Institutions

646

Shares Held

51.8M

Call Options Held

194K

Put Options Held

174K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.54B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janus Henderson Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Janus Henderson Group PLC with notifications on news.

Account

Janus Henderson Group PLC Charles River Laboratories International, Inc. Transaction History